Drug
Canagliflozin clinical trials
Also written Invokana and JNJ-28431754.
- studies test it
- 123
- open now
- 12
- in phase 3
- 22
- first study started
- 2005
Keep track of what changes. Save the Canagliflozin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
122 studies that test it; most in 2014 (19); 1 more planned to start later
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 9 |
| 2009 | 4 |
| 2010 | 12 |
| 2011 | 16 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 19 |
| 2015 | 4 |
| 2016 | 11 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 52
- Phase 2
- 13
- Phase 3
- 22
- Phase 4
- 30
- No phase
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 82 · Other 41
Janssen Research & Development, LLC (37) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (28) · Tanabe Pharma Corporation (11) · University of Maryland, Baltimore (2) · McGill University Health Centre/Research Institute of the McGill University Health Centre (2) · The University of Texas Health Science Center at San Antonio (2) · West China Hospital (2) · University of Colorado, Denver (1)
Often tested with
Tested in the same studies.
Metformin (19) · Sitagliptin (6) · Empagliflozin (5) · Dapagliflozin (5) · Pioglitazone (3) · Extended Release Metformin Hydrochloride (3) · Semaglutide (2) · Vildagliptin (2)
Studies
Open first, then newest update. How each study uses Canagliflozin is read from its arms, and is right about nine times in ten.
Testing it · 123
- Canagliflozin Plus Progestin for Atypical Endometrial Hyperplasia and Early-Stage Endometrial CancerNot yet recruitingPhase 2Wang YingmeiNCT07890064Written as Canagliflozin
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Invokana
- Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid CancerRecruitingPhase 1West China HospitalNCT07703163Written as Canagliflozin
- Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive ImpairmentRecruitingPhase 4Fudan UniversityNCT07711171Written as Canagliflozin group
- CANagliflozin In DIALysis PatientsNot yet recruitingPhase 4University Medical Center GroningenNCT07527390Written as Invokana 300 mg and 100 mg tablet
- Canagliflozin Targeting Vascular InflammationRecruitingPhase 2/3Ottawa Heart Institute Research CorporationNCT05427084Written as Canagliflozin
- SGLT2 Inhibitor Utilization Re-perfusion TherapyNot yet recruitingPhase 4Taichung Veterans General HospitalNCT06858436Written as Canagliflozin 100mg
- The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney DiseaseRecruitingPhase 2National Taiwan University HospitalNCT06528405Written as canagliflozin
- Canagliflozin in Advanced Renal Disease With MRI EndpointsRecruitingPhase 2McGill University Health Centre/Research Institute of the McGill University Health CentreNCT06182839Written as Canagliflozin 300Mg Tab
- Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal CancerRecruitingPhase 1West China HospitalNCT07076823Written as Canagliflozin
- Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary SyndromeNot yet recruitingPhase 4Ping Li,MDNCT06256289Written as Canagliflozin 100mg Tab
- Canagliflozin With Gemcitabine in Pancreatic CarcinomaNot yet recruitingNot applicableZhang Xiaofeng,MDNCT05903703Written as Canagliflozin and Gemcitabine
- Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.CompletedPhase 4Fundación para la Investigación del Hospital Clínico de ValenciaNCT06851962Written as Canagliflozin
- Safety and Efficacy of Canagliflozin in Advanced CKDCompletedPhase 4McGill University Health Centre/Research Institute of the McGill University Health CentreNCT05309785Written as Invokana 300 mg and 100 mg tablet
- Renal Mechanism of SGLT2 InhibitionActive, not recruitingPhase 2University of Colorado, DenverNCT05507892Written as canagliflozin
- Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes MellitusCompletedPhase 4Tanabe Pharma CorporationNCT02220920Written as Canagliflozin (TA-7284)
- Efficacy and Safety Study of TA-7284 in Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT01413204Written as TA-7284 Low
- An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 DiabetesCompletedPhase 2Tanabe Pharma CorporationNCT01022112Written as TA-7284-Low
- Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes MellitusCompletedPhase 4Tanabe Pharma CorporationNCT02227849Written as Canagliflozin (TA-7284)
- Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes MellitusCompletedPhase 4Tanabe Pharma CorporationNCT02622113Written as Canagliflozin (TA-7284)
See all 123 studies that test Canagliflozin →
Given in every arm · 3 — Canagliflozin is usual care beside what is tested
- Preventing High Blood Sugar in People Being Treated for Metastatic Breast CancerActive, not recruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT05090358Written as Canagliflozin
- Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)CompletedPhase 3Tanabe Pharma CorporationNCT02354222Written as Canagliflozin
- A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy VolunteersCompletedPhase 1Janssen-Cilag International NVNCT01877889Written as Canagliflozin
As the comparator · 2 — what is tested is compared with Canagliflozin
- Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 DiabetesStatus unknownPhase 4Nanjing First Hospital, Nanjing Medical UniversityNCT05856578Written as Canagliflozin
- Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03136484Written as Canagliflozin
Codes
What other systems call Canagliflozin · ClinicalTrials.gg INT006557
- MeSH (NLM) D000068896CanagliflozinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0SAC974Z85CANAGLIFLOZINConfirmed FDA, NLM, Wikidata
- RxNorm 1373458Confirmed FDA, Wikidata
- Wikidata Q47495780canagliflozin hemihydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C91018CanagliflozinConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068896 | Canagliflozin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0SAC974Z85 | CANAGLIFLOZIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1373458 | — | Confirmed FDA, Wikidata |
| Wikidata | Q47495780 | canagliflozin hemihydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C91018 | Canagliflozin | Confirmed FDA, Wikidata |
Also registered as canagliflozin anhydrous (UNII 6S49DGR869 · RxNorm 1546031).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.